OpenAI, PerturbAI, and Scripps Research deployed thousands of distributed AI agents to analyze single-cell biological data at a scale no human team could match, surfacing novel research leads from millions of brain cells. The system didn't just process data faster. It identified patterns and candidate targets that traditional analysis pipelines had missed entirely.
The architecture matters here. Using swarms of coordinated agents rather than a single model allowed the system to parallelize hypothesis generation across the dataset, with each agent specializing in subsections of the cellular data before results were aggregated. This is a meaningful shift in how AI gets applied to wet-lab science, moving from assistive summarization to active discovery.
The full piece details the specific agent coordination methods, the biological targets surfaced, and how Scripps researchers are now validating those leads in the lab. If you work in computational biology, drug discovery, or multi-agent system design, the technical architecture section alone justifies the read.
[READ ORIGINAL →]